Robert Gut

1.8k total citations
40 papers, 1.1k citations indexed

About

Robert Gut is a scholar working on Hematology, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Robert Gut has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 14 papers in Genetics and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Robert Gut's work include Hemophilia Treatment and Research (23 papers), Virus-based gene therapy research (7 papers) and Platelet Disorders and Treatments (7 papers). Robert Gut is often cited by papers focused on Hemophilia Treatment and Research (23 papers), Virus-based gene therapy research (7 papers) and Platelet Disorders and Treatments (7 papers). Robert Gut collaborates with scholars based in United States, Netherlands and Italy. Robert Gut's co-authors include Lila E. Nachtigall, John Germak, David L. Cooper, Judith L. Ross, Peter A. Lee, Michael Recht, David F. Archer, James A. Simon, Craig M. Kessler and Morris Notelovitz and has published in prestigious journals such as Blood, The Journal of Pediatrics and Fertility and Sterility.

In The Last Decade

Robert Gut

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Gut United States	21	466	447	359	199	130	40	1.1k
José Luis Rodríguez Gallo Spain	8	219 0.5×	174 0.4×	82 0.2×	45 0.2×	28 0.2×	9	563
S Bernasconi Italy	12	279 0.6×	89 0.2×	119 0.3×	105 0.5×	79 0.6×	42	618
Carles Zafón Spain	18	59 0.1×	518 1.2×	139 0.4×	252 1.3×	70 0.5×	73	968
Meropi Toumba Cyprus	15	203 0.4×	165 0.4×	146 0.4×	203 1.0×	6 0.0×	41	655
Nadine Lucidarme France	10	69 0.1×	144 0.3×	88 0.2×	78 0.4×	21 0.2×	14	372
G. Schellong Germany	11	260 0.6×	64 0.1×	55 0.2×	121 0.6×	117 0.9×	31	676
Masako Waguri Japan	18	36 0.1×	537 1.2×	698 1.9×	165 0.8×	19 0.1×	38	1.4k
Vincenzo De Sanctis Italy	15	324 0.7×	126 0.3×	39 0.1×	56 0.3×	12 0.1×	29	706
A D Leiper United Kingdom	12	205 0.4×	127 0.3×	27 0.1×	94 0.5×	26 0.2×	15	626
Stanislava Koloušková Czechia	23	23 0.0×	531 1.2×	736 2.1×	337 1.7×	48 0.4×	83	1.3k

Countries citing papers authored by Robert Gut

Since Specialization

Citations

This map shows the geographic impact of Robert Gut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Gut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Gut more than expected).

Fields of papers citing papers by Robert Gut

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Gut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Gut. The network helps show where Robert Gut may publish in the future.

Co-authorship network of co-authors of Robert Gut

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Gut. A scholar is included among the top collaborators of Robert Gut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Gut. Robert Gut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Recht, Michael, et al.. (2023). Adults with severe or moderately severe haemophilia B receiving etranacogene dezaparvovec in the HOPE-B phase 3 trial experience a stable increase in mean Factor IX activity levels and durable haemostatic protection after 24 months’ follow-up. Hämostaseologie. 43(S 01). S44–S45. 1 indexed citations

Gut, Robert, et al.. (2018). Hemorrhagic fever with renal syndrome (HFRS) in Poland. Przeglad Epidemiologiczny. 72(4). 477–485. 5 indexed citations

Witkop, Michelle, Anne T. Neff, Tyler W. Buckner, et al.. (2017). Self‐reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P‐FiQ) study. Haemophilia. 23(4). 556–565. 99 indexed citations

Kempton, Christine L., Michael Recht, Anne T. Neff, et al.. (2017). Impact of pain and functional impairment in US adults with haemophilia: Patient‐reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P‐FiQ) study. Haemophilia. 24(2). 261–270. 42 indexed citations

Alice, D., Craig M. Kessler, Hamid Al‐Mondhiry, Robert Gut, & David L. Cooper. (2016). Use of recombinant activated factor VII for acute bleeding episodes in acquired hemophilia. Blood Coagulation & Fibrinolysis. 27(7). 753–760. 19 indexed citations

Kessler, Craig M., D. Alice, Hamid Al‐Mondhiry, Robert Gut, & David L. Cooper. (2016). Assessment of acquired hemophilia patient demographics in the United States. Blood Coagulation & Fibrinolysis. 27(7). 761–769. 38 indexed citations

Ross, Judith L., Peter A. Lee, Robert Gut, & John Germak. (2015). Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years. Growth Hormone & IGF Research. 25(6). 286–293. 31 indexed citations

Gut, Robert, et al.. (2015). Trends In Growth Hormone Stimulation Testing And Growth Hormone Dosing In Adult Growth Hormone Deficiency Patients: Results From The Answer Program. Endocrine Practice. 22(4). 396–405. 21 indexed citations

Rose, Susan R., G. D. Reeves, Robert Gut, & John Germak. (2015). Attention-Deficit/Hyperactivity Disorder Medication Treatment Impact on Response to Growth Hormone Therapy: Results from the ANSWER Program, a Non-Interventional Study. The Journal of Pediatrics. 167(6). 1389–1396. 8 indexed citations

10.

Lentz, Steven R., et al.. (2014). A novel supplemental approach to capturing post-marketing safety information on recombinant factor VIIa in acquired hemophilia: the Acquired Hemophilia Surveillance project. Journal of Blood Medicine. 5. 1–1. 6 indexed citations

11.

Recht, Michael, Ellis J. Neufeld, Vivek R. Sharma, et al.. (2014). Impact of Acute Bleeding on Daily Activities of Patients with Congenital Hemophilia with Inhibitors and Their Caregivers and Families: Observations from the Dosing Observational Study in Hemophilia (DOSE). Value in Health. 17(6). 744–748. 21 indexed citations

12.

Neufeld, Ellis J., Michael Recht, Hernan Sabio, et al.. (2012). Effect of Acute Bleeding on Daily Quality of Life Assessments in Patients with Congenital Hemophilia with Inhibitors and Their Families: Observations from the Dosing Observational Study in Hemophilia. Value in Health. 15(6). 916–925. 51 indexed citations

13.

Lee, Peter A., Judith L. Ross, John Germak, & Robert Gut. (2012). Effect of 4 years of growth hormone therapy in children with Noonan syndrome in the American Norditropin Studies: Web-Enabled Research (ANSWER) Program® registry. International Journal of Pediatric Endocrinology. 2012(1). 15–15. 28 indexed citations

14.

Young, Guy, Amy D. Shapiro, Christopher Walsh, et al.. (2011). Patient/Caregiver‐reported recombinant factor VIIa (rFVIIa) dosing: home treatment of acute bleeds in the Dosing Observational Study in Hemophilia (DOSE). Haemophilia. 18(3). 392–399. 22 indexed citations

15.

Lee, Peter A., John Germak, Robert Gut, Naum Khutoryansky, & Judith L. Ross. (2011). Identification of factors associated with good response to growth hormone therapy in children with short stature: results from the ANSWER Program®. International Journal of Pediatric Endocrinology. 2011(1). 6–6. 35 indexed citations

16.

Ross, Judith L., Peter A. Lee, Robert Gut, & John Germak. (2011). Impact of Age and Duration of Growth Hormone Therapy in Children with Turner Syndrome. Hormone Research in Paediatrics. 76(6). 392–399. 23 indexed citations

17.

Ross, Judith L., Peter A. Lee, Robert Gut, & John Germak. (2010). Factors Influencing the One- and Two-Year Growth Response in Children Treated with Growth Hormone: Analysis from an Observational Study. International Journal of Pediatric Endocrinology. 2010. 1–7. 36 indexed citations

18.

Simon, James A., et al.. (2008). Effective Treatment of Vaginal Atrophy With an Ultra–Low-Dose Estradiol Vaginal Tablet. Obstetrics and Gynecology. 112(5). 1053–1060. 120 indexed citations

19.

Bachmann, Gloria, Rogerio A. Løbo, Robert Gut, Lila E. Nachtigall, & Morris Notelovitz. (2008). Efficacy of Low-Dose Estradiol Vaginal Tablets in the Treatment of Atrophic Vaginitis. Obstetrics and Gynecology. 111(1). 67–76. 121 indexed citations

20.

Panay, Nicholas, et al.. (2007). Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief. Climacteric. 10(2). 120–131. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact